BusinessWire India.com - Health Care News Summary http://www.businesswireindia.com/rss en-us 15 businesswireindia.com 188 97 http://www.businesswireindia.com/rss <![CDATA[Merck KGaA and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302]]> Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that]]>